Neuro Central

Neurology and neuroscience are rapidly evolving fields that play a crucial role in medical and scientific advancements. Neuro Central, an online platform from Future Science Group, brings together all elements of neurology and neuroscience to foster collaboration and learning. By connecting fundamental research with clinical applications, Neuro Central offers valuable insights and is supported by an expanding team of global experts. Our platform provides high-quality, relevant content in an engaging and user-friendly format. Stay informed with the latest news, expert opinions, peer-reviewed articles, multimedia resources, and exclusive content that is easy to read and understand.

International, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#8748629

Country

N/A

Articles

Novel enhancers linked to Parkinson’s and schizophrenia

1 month ago | neuro-central.com | Annie Coulson

A comprehensive analysis has identified novel enhancers associated with neuronal development and disease. An international collaboration of researchers led by Masahito Yoshihara at Chiba University (Japan) has identified novel transcriptional enhancers that regulate gene expression in neuronal development and might be implicated in neuropsychiatric conditions like Parkinson’s and schizophrenia. The study uncovers new avenues for neuropsychiatric drug development. Read the full news article here
Call for Papers - Neuropsychiatric Disease and Treatment: AI and machine learning in neuropsychiatric disease diagnosis, prognosis and treatment

1 month ago | neuro-central.com | Annie Coulson

Do you have original research or review papers you wish to publish on how applications of artificial intelligence (AI), machine learning (ML) and data mining (DM) can improve the diagnosis, treatment and management of neuropsychiatric diseases? Neuropsychiatric Disease and Treatment invites you to submit your paper to its latest Article Collection entitled ‘Artificial intelligence and machine learning in neuropsychiatric disease diagnosis, prognosis and treatment’.
New biomarker test could detect Alzheimer’s years before symptoms appear

2 months ago | neuro-central.com | Annie Coulson

The test can identify misfolded tau proteins years earlier than traditional imaging, enabling earlier Alzheimer’s diagnosis and improving treatment effectiveness.
Do microglia hold the key to managing melanoma brain metastases?

2 months ago | neuro-central.com | Annie Coulson

Researchers have identified a key role microglia play in the progression of melanoma brain metastases. A research team led by Berta Sanchez-Laorden at theĀ Institute for Neurosciences (Alicante, Spain) has identified that a transcriptomic shift and subsequent activation of a key signaling pathway occurs in microglia during melanoma brain metastases progression. Targeting this pathway could promote antitumor immunity and improve responses to immunotherapies. Read the full news article here
Call for Papers – Stress: Stress and sex: gonads, hormones and receptors

2 months ago | neuro-central.com | Annie Coulson

Do you have original research or review papers you wish to publish on sex-specific factors and their role in stress? Stress invites you to submit your paper to its latest Article Collection entitled ‘Stress and sex: gonads, hormones and receptors’. Emerging evidence indicates that the processing of stressors and subsequent biological responses are modulated by sex-specific factors, including gonadal hormones and receptors.
Jumpstarting brain repair: promising stem cell therapy for ischemic stroke

2 months ago | neuro-central.com | Annie Coulson

A stem-cell therapy has demonstrated promise for ischemic stroke treatment, offering potential advantages over current conventional options. In a recent study, researchers at the Gladstone Institutes (CA, USA) highlighted the transformative potential of SB623, a stem cell therapy for ischemic stroke.
NIH freezes rock the research world

2 months ago | neuro-central.com | Annie Coulson

NIH reviews, travel and communications have been frozen until 2 February at least. How has the scientific community responded? On day three of Trump’s presidency, the administration imposed a wide range of restrictions on the National Institutes of Health (NIH; MD, USA), including cancelling research-grant reviews, travel, training, meetings and communications. Webpages concerning diversity programs and grants have also disappeared. Read the full news article here
Call for Papers - Dialogues in Clinical Neuroscience: Examining psychopathology across the neurodevelopmental continuum

2 months ago | neuro-central.com | Annie Coulson

Do you have original research or review papers you wish to publish giving perspectives on the interplay between neurodevelopment and psychopathology? Dialogues in Clinical Neuroscience invites you to submit your paper to its latest Article Collection entitled ‘Examining psychopathology across the neurodevelopmental continuum: a complex two-way relationship with many unanswered questions’.
Mapping the brain to find out more about schizophrenia

Dec 10, 2024 | neuro-central.com | Annie Coulson

Brain mapping reveals the circuitry involved in distinguishing self-generated sounds from external noises, advancing our understanding of human speech and auditory hallucinations. Have you ever wondered how we distinguish self-generated sounds from external sounds? A team, led by researchers from NYU Langone Health, its Neuroscience Institute and NYU Tandon School of Engineering (all NY, USA), was curious, which led them to devise a study to investigate the underlying neural circuitry.
Call for Papers - Pain Management: Non-opioid treatments in pain management

Dec 10, 2024 | neuro-central.com | Annie Coulson

Do you have original research or review papers you wish to publish on non-opioid treatments in pain management? Pain Management invites you to submit your paper to its latest Article Collection. Pain is a common, complex and distressing problem, affecting millions of people worldwide and exerting a huge social and economic burden. Opioids are commonly used to manage both acute and chronic pain, and the use of prescription opioids has increased dramatically over recent decades.